Back

Plasma proteome signatures in sickle cell anaemia and effect of hydroxyurea treatment

2026-02-10 hematology Title + abstract only
View on medRxiv
Show abstract

BackgroundSickle Cell Anaemia (SCA), a genetic blood disorder caused by a single mutation in the beta globin gene, displays a highly variable clinical course. Hydroxyurea (HU), an effective treatment, has an unclear mechanism of action. Plasma proteins can act as biomarkers for understanding disease states and response to HU treatment in SCA patients. MethodsPlasma proteome profiling of 31 healthy individuals and 76 SCA patients, including those with and without HU treatment, was performed usin...

Predicted journal destinations